Minig, L.
87  Ergebnisse:
Personensuche X
?
 
?
 
?
3

Pathology findings and clinical outcomes after risk reducti..:

Minig, L. ; Cabrera, S. ; Oliver, R....
Clinical and Translational Oncology.  20 (2018)  10 - p. 1337-1344 , 2018
 
?
4

Optimization of surgical treatment of advanced ovarian canc..:

Minig, L. ; de Santiago, J. ; Domingo, S....
Clinical and Translational Oncology.  21 (2018)  5 - p. 656-664 , 2018
 
?
5

Current situation in gynecological oncology training in Spa..:

Padilla-Iserte, P. ; Minig, L. ; Zapardiel, I....
Clinical and Translational Oncology.  20 (2017)  4 - p. 517-523 , 2017
 
?
6

Feasibility of robotic radical hysterectomy after neoadjuva..:

Minig, L. ; Zanagnolo, V. ; Cárdenas-Rebollo, J.M...
European Journal of Surgical Oncology (EJSO).  42 (2016)  9 - p. 1372-1377 , 2016
 
?
8

Therapeutic management of epithelial ovarian cancer during ..:

Minig, L. ; Otaño, L. ; Diaz-Padilla, I....
Clinical and Translational Oncology.  15 (2012)  4 - p. 259-264 , 2012
 
?
10

Early Oral Versus "Traditional" Postoperative Feeding in Gy..:

Minig, L. ; Biffi, R. ; Zanagnolo, V....
Annals of Surgical Oncology.  16 (2009)  6 - p. 1660-1668 , 2009
 
?
12

The effect of early versus delayed postcaesarean feeding on..:

Izbizky, GH ; Minig, L ; Sebastiani, MA.
BJOG: An International Journal of Obstetrics & Gynaecology.  115 (2008)  3 - p. 332-338 , 2008
 
?
13

Procalcitonin and C‐reactive protein as early markers of an..:

Sánchez‐Iglesias, José Luis ; Morales‐Coma, Clara ; Minig, Lucas...
Acta Obstetricia et Gynecologica Scandinavica.  103 (2024)  7 - p. 1302-1310 , 2024
 
1-15